Susquehanna Portfolio Strategies’s Stoke Therapeutics STOK Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio STOK Stock Details STOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$287K	Sell	8,775 -110,451	-93%	-$3.54M	﹤0.01%	751
2026 Q1	$3.88M	Sell	119,226 -7,124	-6%	-$234K	0.06%	347
2025 Q4	$4.01M	Hold	126,350	–	–	0.06%	345
2025 Q3	$2.97M	Hold	126,350	–	–	0.05%	420
2025 Q2	$1.43M	Buy	126,350 +111,600	+757%	+$1.06M	0.03%	443
2025 Q1	$98.1K	Buy	+14,750	New	+$138K	0.04%	147
2024 Q3	–	Sell	-43,424	Closed	-$587K	–	478
2024 Q2	$587K	Hold	43,424	–	–	0.02%	344
2024 Q1	$586K	Sell	43,424 -1,684	-4%	-$10.2K	0.01%	560
2023 Q4	$237K	Buy	+45,108	New	+$193K	﹤0.01%	907

Other funds holding STOK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Susquehanna Portfolio Strategies's STOK Position: Q2 2026 in Review

Susquehanna Portfolio Strategies reduced its Stoke Therapeutics (STOK) stake by 93% in Q2 2026, selling an estimated $3.54M and leaving 8,775 shares worth $287K. The position accounts for ﹤0.01% of the portfolio, ranked #751.

Susquehanna Portfolio Strategies first reported a position in STOK in Q4 2023 and has held it in 9 quarters since. The position peaked at $4.01M in Q4 2025. 197 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

Susquehanna Portfolio Strategies held 8,775 shares of Stoke Therapeutics worth $287K as of Q2 2026.
Susquehanna Portfolio Strategies sold 110,451 Stoke Therapeutics shares in Q2 2026, an estimated $3.54M.
Stoke Therapeutics made up ﹤0.01% of Susquehanna Portfolio Strategies's portfolio in Q2 2026, its #751 holding.
Susquehanna Portfolio Strategies first reported a position in Stoke Therapeutics in Q4 2023 and has held it in 9 quarters since.
Susquehanna Portfolio Strategies's Stoke Therapeutics position peaked at $4.01M in Q4 2025.
197 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.